Skip to content
CompanySight
Company No. 09507173 · Incorporated 24 Mar 2015

Mark Thompson Lifesciences Ltd.

Registered name: MARK THOMPSON LIFESCIENCES LTD.

Part of Normec Holding UK Limited group

Mark Thompson Lifesciences Ltd. does not publish its revenue or profit. Its accounts to 31 Dec 2024 show net assets of £413k and 3 employees.

Mark Thompson Lifesciences Ltd. did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Dec 2024 showed net assets of £413k and 3 employees. The company is classified under “management consultancy activities other than financial management” and is based in Bishop Auckland; we hold 4 years of its filed accounts.

Balance sheet onlySection M · Professional, scientific and technical activitiesSIC 70229Management consultancy activities other than financial management
Status
Active
Location
Bishop Auckland, North East
Age
11 yrs · since 2015
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2024

Key figures

Small team

Revenue not disclosed

Mark Thompson Lifesciences Ltd.’s accounts for the year to 31 Dec 2024 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
3
Net assets
£413k

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Mar 202231 Mar 202331 Mar 202431 Dec 2024
DisclosureNo P&LNo P&LNo P&LNo P&L
Profit & loss
Revenue (turnover)————
Profit (best available)————
Employees (average)4443
Ratios
Profit margin————
Growth (year on year)
Headcount growth—0%0%—
Balance sheet — indirect signals, not revenue
Cash at bank£6.2k£236£3.2k£45.3k
Net assets£213k£188k£285k£413k
Fixed assets£63.9k£80k£60k£53.5k
Current assets£366k£361k£459k£533k
Debtors£146k£153k£90.6k£54.3k
SourceFullAccounts · bulk data Dec 2023FullAccounts · bulk data Dec 2023FullAccounts · bulk data Dec 2024FullAccounts · bulk data Oct 2025
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now £413k
Cash at bank
—
Now £45.3k
Headcount
—
Now 3
Deferred income
—
Now —
Fixed assets
—
Now £53.5k
Corporate ownership

Group structure

Ownership chain

  1. Normec Holding UK Limitedultimate parent50–75%
  2. Mark Thompson Lifesciences Ltd.this company

Bands show the share of ownership each company holds in the one below it.

Sister companies (11)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2024, from the Companies House accounts bulk data published Oct 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.